Prostate Cancer - news item 1 of 49
|
|
A cell- surface polymer reptation mechanism for tumor transendothelial transport of macromolecules.
|
|
Related Articles A cell- surface polymer reptation mechanism for tumor transendothelial transport of macromolecules. Technol Cancer Res Treat. 2008 Jun;7(3):257-68 Authors: Uzgiris EE Polymer reptation is a process by which flexible linear polymers can migrate around obstacles and through pores and around other polymer molecules. It has successfully described quantitative...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 11:08:30 am
|
|
|
|
Prostate Cancer - news item 2 of 49
|
|
Vitamin d may prevent prostate cancer
|
|
ROCHESTER, N.Y., May 15 (UPI) -- Vitamin D not only can be used as a therapy for prostate cancer, it can prevent prostate cancer, a University of Rochester Medical Center suggests. (Source: United Press International - Health Business)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 5:02:10 am
|
|
|
|
Prostate Cancer - news item 3 of 49
|
|
Expression and sub-cellular localization of the ccaat/enhancer binding protein [alpha] in relation to postnatal development and malignancy of the prostate
|
|
C/EBP[alpha] is a critical mediator of terminal differentiation and a tumor suppressor through its strong antiproliferative actions on cell cycle regulatory proteins. C/EBP[alpha] also appears to regulate androgen receptor (AR) AR signaling. There, is a paucity of information on the expression and sub-cellular localization of C/EBP[alpha] in normal mouse and...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 4 of 49
|
|
Aua 2008: higher cholesterol increases the risk of biochemical failure after radical prostatectomy
|
|
(American Urological Association) Poor cholesterol management may not only affect a man's risk for prostate cancer, but also his risk of biomedical recurrence after prostatectomy, according to new data from Duke University. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 5 of 49
|
|
Race, family history or baseline psa: which best predicts prostate cancer risk?
|
|
(American Urological Association) African-American men with family histories of prostate cancer could benefit from a baseline prostate-specific antigen (PSA) reading to determine their probability of developing the disease. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 6 of 49
|
|
External-beam radiation therapy for localized prostate cancer linked to other cancer
|
|
(American Urological Association) Patients undergoing external-beam radiation therapy for localized prostate cancer may be at an increased risk for secondary malignancy, according to a study from researchers in Canada, Italy and the United States. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 7 of 49
|
|
New study strengthens association of prostate cancer with exposure to agent orange
|
|
(American Urological Association) As men age, their risk of developing prostate cancer increases. Aging Vietnam veterans are giving researchers new opportunities to solidify the connection between in-country exposure to Agent Orange and subsequent prostate cancer development. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 8 of 49
|
|
Aua 2008: legislation needed to provide coverage for ed treatment after prostatectomy
|
|
(American Urological Association) Men who have developed erectile dysfunction following surgery for prostate cancer usually do not have insurance coverage for ED treatment even though their insurance policies cover surgery for prostate cancer. In contrast, federal law requires that insurance companies which cover mastectomy for breast cancer treatment also cover...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 9 of 49
|
|
Aua 2008: baseline psa reading a reliable prostate cancer predictor for up to 30 years
|
|
(American Urological Association) Premalignant phases of prostate cancer occur over long periods of time and a single prostate-specific antigen reading taken at age 44-50 can help predict prostate cancer diagnosis up to 30 years subsequently, according to updated data from researchers in New York and Malmo, Sweden. The findings expand...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 10 of 49
|
|
Therapeutic vaccine prolongs survival and improves quality of life
|
|
(American Urological Association) A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by enabling their immune systems to fight the disease. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 11 of 49
|
|
Aua 2008: active surveillance a viable option for low-risk prostate cancer
|
|
(American Urological Association) Active surveillance remains a viable option for low-risk, localized prostate cancer. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 12 of 49
|
|
Aua 2008: access to urologists and prostate cancer screenings lead to better outcomes for patients
|
|
(American Urological Association) Men with greater access to prostate cancer screenings and treatment have better outcomes from the disease, a new study shows. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 13 of 49
|
|
Regular prostate-specific antigen screening may be discontinued in certain elderly populations
|
|
(American Urological Association) Men aged 75-80 with prostate-specific antigen levels less than 3 ng/ml may be able to discontinue their regular prostate cancer screenings. (Source: EurekAlert! - Medicine and Health)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 14 of 49
|
|
Reducing intake of dietary fat prevents prostate cancer in mice
|
|
(University of California - Los Angeles) Scientists with UCLA's Jonsson Cancer Center and the Department of Urology have showed that lowering intake of the type of fat common in a Western diet helps prevent prostate cancer in mice, the first finding of its kind in a mouse model that closely...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 15 of 49
|
|
Genes may play role in risk assessment for prostate cancer among hispanics and caucasians
|
|
(American Association for Cancer Research) Genetic differences may explain the greater risk for prostate cancer among Caucasian men compared with Hispanic men, which could help clinicians predict who is more likely to develop the disease, according to a paper published in the May 15, 2008, issue of Clinical Cancer Research,...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 16 of 49
|
|
Protest planned to demonstrate against fda's failure to approve provenge
|
|
Several healthcare groups are planning to stage demonstrations on May 30 over FDA's decision not to approve Provenge for prostate cancer. (Source: Drug Topics - Hot off the Press)
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 17 of 49
|
|
Prosaposin is an ar-target gene and its neurotrophic domain upregulates ar expression and activity in prostate stromal cells
|
|
Recent studies have introduced prosaposin (PSAP) as a pleiotrophic growth factor for prostate cancer (PCa). We have previously reported that PSAP or one of its known active molecular derivatives, saposin C functions as an androgen-agonist and androgen-regulated gene (ARG) for androgen-sensitive (AS) PCa cell lines. Due to the potential significance...
|
|
RSS Source: Med Worm - Prostate Cancer Thu, 15 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 18 of 49
|
|
Active surveillance for early-stage prostate cancer: review of the current literature
|
|
BERKELEY, CA (UroToday.com) - In the online version of Cancer, Dr. Dall'Era and colleagues provide a comprehensive overview of active... (Source: UroToday)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 11:00:00 pm
|
|
|
|
Prostate Cancer - news item 19 of 49
|
|
Mayo clinic validation of the d'amico risk group classification for predicting survival ...
|
|
BERKELEY, CA (UroToday.com) - Dr. Boorjian and colleagues from the Mayo Clinic validate the D'Amico risk classification of predicting survival... (Source: UroToday)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 11:00:00 pm
|
|
|
|
Prostate Cancer - news item 20 of 49
|
|
Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors ...
|
|
BERKELEY, CA (UroToday.com) - Up to 16% of men undergoing surgical treatment for BPH will be found to have prostate... (Source: UroToday)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 11:00:00 pm
|
|
|
|
Prostate Cancer - news item 21 of 49
|
|
Fda approves hifu clinical trial for recurrent prostate cancer
|
|
USHIFU, the clinical trial management provider for Focus Surgery, Inc. (Indianapolis, IN), is pleased to announce conditional written approval pending minor changes to the protocol from the FDA to begin a pivotal trial for the treatment of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external...
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 11:00:00 am
|
|
|
|
Prostate Cancer - news item 22 of 49
|
|
Robotic surgery first for christie
|
|
The Christie Hospital has introduced a high-tech new robot so surgeons can use the latest technology to treat prostate cancer. (Source: Christie Hospital NHS Foundation Trust)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 9:00:54 am
|
|
|
|
Prostate Cancer - news item 23 of 49
|
|
[rsna education exhibits] the inguinal canal: anatomy and imaging features of common and uncommon masses
|
|
A variety of benign and malignant masses can be found in the inguinal canal (IC). Benign causes of masses in the IC include spermatic cord lipoma, hematoma, abscess, neurofibroma, varicocele, desmoid tumor, air, bowel contrast material, hydrocele, and prostheses. Primary neoplasms of the IC include liposarcoma, Burkitt lymphoma, testicular carcinoma,...
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 24 of 49
|
|
Cme: case 15-2008: a 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer
|
|
(No abstract is available for this citation) (Source: New England Journal of Medicine)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 25 of 49
|
|
Case records of the massachusetts general hospital: case 15-2008 -- a 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer
|
|
A 55-year-old man was referred to this hospital for management of prostate cancer. An elevated serum prostate specific antigen (PSA) level was found during evaluation of urinary symptoms; core needle biopsies of the prostate disclosed adenocarcinoma, with a Gleason score of 6 out of 10. Examination and computed tomography showed...
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 26 of 49
|
|
Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies
|
|
Prostate cancer (PC) is major common malignancy in males in most industrialized Western countries, where it is the most commonly diagnosed cancer affecting men after middle age (>50 years). Over 90% of PC patients with incurable disease respond to primary treatment, which consists of intervention to lower serum testosterone. However,...
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 27 of 49
|
|
Re: androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
|
|
Related Articles Re: androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Eur Urol. 2008 Jun;53(6):1297 Authors: Mongiat-Artus P PMID: 18471559 [PubMed - in process] (Source: European Urology)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 12:39:58 am
|
|
|
|
Prostate Cancer - news item 28 of 49
|
|
Re: stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ara70.
|
|
Related Articles Re: Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-activator ARA70. Eur Urol. 2008 Jun;53(6):1298 Authors: Culig Z PMID: 18471560 [PubMed - in process] (Source: European Urology)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 12:39:56 am
|
|
|
|
Prostate Cancer - news item 29 of 49
|
|
Re: cumulative association of five genetic variants with prostate cancer.
|
|
Related Articles Re: cumulative association of five genetic variants with prostate cancer. Eur Urol. 2008 Jun;53(6):1298-9 Authors: Klotz L PMID: 18471561 [PubMed - in process] (Source: European Urology)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 12:39:53 am
|
|
|
|
Prostate Cancer - news item 30 of 49
|
|
Re: effect of alpha1-adrenoreceptor antagonist exposure on prostate cancer incidence: an observational cohort study.
|
|
Related Articles Re: Effect of alpha1-Adrenoreceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study. Eur Urol. 2008 Jun;53(6):1300 Authors: Sarramon JP PMID: 18471562 [PubMed - in process] (Source: European Urology)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 12:39:49 am
|
|
|
|
Prostate Cancer - news item 31 of 49
|
|
Cancer appeal urges men to be vigilant
|
|
A LOTHIANS support group has urged men to check themselves out for prostate cancer as part of an awareness week. (Source: Scotsman.com News - Health)
|
|
RSS Source: Med Worm - Prostate Cancer Wed, 14 May 2008 12:00:00 am
|
|
|
|
Prostate Cancer - news item 32 of 49
|
|
Edap adds premiere m.d. anderson cancer center for phase ii/iii ablatherm-hifu clinical trial
|
|
LYON, France, May 13, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (NasdaqGM:EDAP ), the global leader in therapeutic ultrasound, announced today that The University of Texas M.D. Anderson Cancer Center in Houston, Texas received Institutional Review Board (IRB) a... Devices, OncologyEDAP TMS, Ablatherm, High Intensity Focused Ultrasound, HIFU, prostate cancer (Source:...
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 10:10:28 pm
|
|
|
|
Prostate Cancer - news item 33 of 49
|
|
Is there any evidence that treatment holidays for patients receiving lhrh antagonists for prostate cancer is ethical and effective?
|
|
In answering this question, we have interpreted treatment holidays to mean intermittent rather than a continuous treatment regimen. We searched the NLH Cancer Specialist Library and the TRIP and Medline databases but found little robust information on the efficacy of the use of intermittent LHRH antagonists in prostate cancer. (Source:...
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 4:21:03 pm
|
|
|
|
Prostate Cancer - news item 34 of 49
|
|
Antidepressants and risk of prostate cancer: a nested case-control study
|
|
This study examined the association between antidepressant drug use and risk of prostate cancer. Prostate Cancer and Prostatic Diseases (Source: Medscape Hematology-Oncology Headlines)
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 2:35:19 pm
|
|
|
|
Prostate Cancer - news item 35 of 49
|
|
Ei-nav/artemis helps pinpoint prostate cancer, provides a map for follow-up care
|
|
GRASS VALLEY, Calif. -- A new imaging device, ei-Nav/Artemis(TM), now officially cleared by the U.S. Food and Drug Administration (FDA), offers urologists breakthrough technology that will significantly help in the fight against prostate cancer. Artemis, designed by Eigen, a Northern California-based company known for developing innovative, affordable medical imaging solutions,...
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 4:36:00 am
|
|
|
|
Prostate Cancer - news item 36 of 49
|
|
Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?
|
|
Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer? Prostate Cancer and Prostatic Diseases advance online publication, May 13, 2008. doi:10.1038/pcan.2008.31 Authors: J M Mayes, V Mouraviev, L Sun, J F Madden & T J Polascik (Source: Prostate Cancer and Prostatic Diseases)
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 37 of 49
|
|
Quality of life in patients with prostate cancer: development and application of a hybrid assessment method
|
|
Quality of life in patients with prostate cancer: development and application of a hybrid assessment method Prostate Cancer and Prostatic Diseases advance online publication, May 13, 2008. doi:10.1038/pcan.2008.28 Authors: P C Stone, R F Murphy, H E Matar & M Q Almerie (Source: Prostate Cancer and Prostatic Diseases)
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 38 of 49
|
|
Molecular targeting of bcl-2 overcomes prostate cancer cell adaptation to xiap gene downregulation
|
|
Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation Prostate Cancer and Prostatic Diseases advance online publication, May 13, 2008. doi:10.1038/pcan.2008.27 Authors: Y Nakano, V Bilim, K Yuuki, A Muto, T Kato, A Nagaoka & Y Tomita (Source: Prostate Cancer and Prostatic Diseases)
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 39 of 49
|
|
Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines
|
|
Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines Prostate Cancer and Prostatic Diseases advance online publication, May 13, 2008. doi:10.1038/pcan.2008.23 Authors: M St John Floyd, S J Teahan, J M Fitzpatrick & R W G Watson (Source: Prostate Cancer and Prostatic Diseases)
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 4:00:00 am
|
|
|
|
Prostate Cancer - news item 40 of 49
|
|
Spermine oxidase expression increased in prostate cancer patients
|
|
Patients with prostate cancer and prostatic intraepithelial neoplasia have higher spermine oxidase expression in areas of prostatic disease and in prostatic epithelial cells overall than healthy individuals, US study findings suggest. (Source: MedWire News - Oncology)
|
|
RSS Source: Med Worm - Prostate Cancer Tue, 13 May 2008 12:46:32 am
|
|
|
|
Prostate Cancer - news item 41 of 49
|
|
Beyond the abstract - erectile dysfunction after external beam radiotherapy for prostate cancer
|
|
BERKELEY, CA (UroToday.com) - Currently, the most common curative treatment options for men with localized prostate cancer are radical prostatectomy,... (Source: UroToday)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 11:00:00 pm
|
|
|
|
Prostate Cancer - news item 42 of 49
|
|
Pca3 could be useful in selecting prostate cancer patients for active surveillance
|
|
A urine test already marketed for diagnosing prostate cancer could also be useful for guiding management if further studies validate these results. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 9:00:00 pm
|
|
|
|
Prostate Cancer - news item 43 of 49
|
|
Doctors try suffocating stubborn tumors - cutting off blood supply, nutrients may help in pancreatic cancer
|
|
Over the last 30 years, researchers have made some impressive strides inbattling certain types of cancer. It's estimated, for example, that 99% of prostate cancer patients will survive at least five years and 9 out of 10 breast cancer patients will too.* While the numbers may not be quite as...
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 4:00:00 pm
|
|
|
|
Prostate Cancer - news item 44 of 49
|
|
Radiation in high-risk prostate cancer: how much is enough?
|
|
BJU International, Volume 0, Issue 0, Page ???, OnlineEarly Articles. (Source: BJU International)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 12:07:40 pm
|
|
|
|
Prostate Cancer - news item 45 of 49
|
|
Analysis of complex protein kinase b signalling pathways in human prostate cancer samples
|
|
BJU International, Volume 0, Issue 0, Page ???, OnlineEarly Articles. OBJECTIVE To provide a rational basis for targeted treatment approaches in prostate cancer deregulation of the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (PKB/Akt) system was analysed. PATIENTS AND METHODS In all, 45 patients with primary ... (Source: BJU International)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 12:07:07 pm
|
|
|
|
Prostate Cancer - news item 46 of 49
|
|
What is the future of prostate-specific antigen for the early detection of prostate cancer?
|
|
BJU International, Volume 0, Issue 0, Page ???, OnlineEarly Articles. (Source: BJU International)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 12:07:06 pm
|
|
|
|
Prostate Cancer - news item 47 of 49
|
|
Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound
|
|
BJU International, Volume 0, Issue 0, Page ???, OnlineEarly Articles. Study Type – Diagnostic (case series)Level of Evidence 4 OBJECTIVE To assess the role of magnetic resonance imaging (MRI) for evaluating changes in the prostate after transrectal high-intensity focused ultrasound (HIFU) for treating prostate cancer, ... (Source: BJU International)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 12:06:50 pm
|
|
|
|
Prostate Cancer - news item 48 of 49
|
|
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer
|
|
BJU International, Volume 0, Issue 0, Page ???, OnlineEarly Articles. Study Type – Prognosis (retrospective cohort study)Level of Evidence 2b OBJECTIVE To assess the relationship between surgical volume (SV), defined as the number of radical prostatectomies (RPs) within a calendar year, and the time to secondary therapy (... (Source: BJU International)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 12:06:49 pm
|
|
|
|
Prostate Cancer - news item 49 of 49
|
|
Newer prostate cancer treatment similar to traditional surgery
|
|
Title: Newer Prostate Cancer Treatment Similar to Traditional SurgeryCategory: Health NewsCreated: 5/11/2008 2:00:00 AMLast Editorial Review: 5/12/2008 (Source: MedicineNet Mens Health General)
|
|
RSS Source: Med Worm - Prostate Cancer Mon, 12 May 2008 7:00:00 am
|
|
|